Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Up 45.0% in September

Aspira Women’s Health Inc. (NASDAQ:AWH) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 379,300 shares, an increase of 45.0% from the August 31st total of 261,600 shares. Based on an average trading volume of 123,400 shares, the days-to-cover ratio is presently 3.1 days. Currently, 3.4% of the company’s shares are sold short.

Aspira Women’s Health Price Performance

Shares of AWH stock remained flat at $0.83 during trading hours on Friday. The stock had a trading volume of 60,038 shares, compared to its average volume of 69,693. The company has a market capitalization of $10.27 million, a PE ratio of -0.57 and a beta of 1.48. Aspira Women’s Health has a 12-month low of $0.74 and a 12-month high of $6.01. The business’s 50 day moving average is $1.06 and its two-hundred day moving average is $2.01.

Aspira Women’s Health (NASDAQ:AWH) last released its quarterly earnings results on Monday, August 12th. The company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.04. The firm had revenue of $2.42 million for the quarter, compared to the consensus estimate of $2.60 million. During the same quarter in the prior year, the firm earned ($0.28) earnings per share. Analysts expect that Aspira Women’s Health will post -1.26 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on AWH. StockNews.com upgraded Aspira Women’s Health from a “sell” rating to a “hold” rating in a research report on Tuesday, September 24th. Alliance Global Partners cut their price objective on Aspira Women’s Health from $7.00 to $5.50 and set a “buy” rating on the stock in a research report on Wednesday, August 14th.

Institutional Investors Weigh In On Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. lifted its position in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) by 43.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 179,371 shares of the company’s stock after purchasing an additional 53,997 shares during the quarter. B. Riley Wealth Advisors Inc. owned about 1.73% of Aspira Women’s Health worth $732,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 12.19% of the company’s stock.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.